Delivery Order SPE2DR25D1104-SPE2DR26FL324

<p>The Defense Logistics Agency issued a $8,538.78 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Latuda 60 mg tablets (30-count).</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 25, 2026. Pricing is firm fixed price. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 23, 2026, for Latuda 20 mg tablets (30-count unit) with a ceiling value of $5,470.69.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 24, 2026.</p>

<p>The Defense Logistics Agency issued a $5,302.69 delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for Latuda 120 mg tablets (30-count).</p> <p>The order is issued under Amerisourcebergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is February 24, 2026. Pricing is firm fixed price with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 20, 2026, with a ceiling value of $13,121.87 for supply of Latuda 20 mg tablets (30-count). Place of performance is Conshohocken, PA. Ultimate completion date is February 23, 2026.</p>

The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,377.96 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count package) under a firm fixed-price contract. The award was issued on November 7, 2025, with an ultimate completion date of November 10, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This non-competitive delivery order represents a small-value pharmaceutical procurement supporting federal medical...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Latuda 120 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $9,820.56. The order is scheduled for completion by November 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's proven...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,653.85 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on November 13, 2025, with an ultimate completion date of November 14, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....

The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Latuda 60 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,418.64 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...

The Defense Logistics Agency awarded a $163,360 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 packages of 20mg Latuda tablets. The order is to be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 28, 2023 in support of the Defense Logistics Agency's pharmaceutical procurement programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceutical supply vehicle to...

The Defense Logistics Agency awarded a delivery order valued at $6,295.43 to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count units). This firm fixed-price, non-set-aside contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...